Coates International, Ltd. Received Official Notification

New Post Public Reply Private Reply Replies (0) Message Board
vegasandre
453
Coates International, Ltd. Received Official Notification From Secure Supplies Mexico LLC That the Solar System Project in Mexico is Budgeted for $412,000,000 USD Over a Three Year Period to Completion - Coates International, Ltd. is to Manufacture and Deliver a Number of Large Industrial CSRV Electric Power Generators That Will Operate on Hydrogen - on Site Revenues From This Transaction to the Company Will be Approximately $40,000,000 USD


WALL TOWNSHIP, N.J., April 19, 2017 (GLOBE NEWSWIRE) -- Coates International, Ltd. (OTC PINK:COTE) (the “Company”) received official notification from Secure Supplies Mexico LLC that the solar system project in Mexico is budgeted for $412,000,000 USD over a three year period. The Company will deliver 40 to 50 CSRV large industrial electric power generators to operate on gaseous hydrogen produced on site.

Company President and CEO, Mr. George J. Coates, comments: “This is only one of the projects that our Company is involved in with Secure Supplies. These projects work in the following way: Secure Supplies set out on the site where hundreds of solar panels are erected producing electric power and producing hydrogen, which is stored in special expansion tanks. When the sun goes down, the Coates CSRV electric power generators fire up operating on the stored hydrogen, which is produced by the sun. These CSRV generators are synchronous and only produce the power required at any given time up to 50 M.W. These are the most “green” projects ever. These projects are many worldwide. Coates CSRV engines are the only engine suitable to operate on gaseous hydrogen continuously.

Coates International (COTE) Stock Research Links

COTE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nvidia's Major $500 Million Investment in Wayve for AI Expansion

Updated Category News Views 206

Nvidia Invests $500 Million in Wayve Nvidia, known for its advanced AI technologies, is in discussions to invest a substantial $500 million into the U.K.-based autonomous driving startup Wayve. This move marks a significant step for Nvidia as it seeks to deepen its involvement in the rapidly evolving artificial intelligence sector. Strategic Importance of the Investment...

Continue Reading
Vortex Companies Enhances Leadership with Key Promotions

Updated Category News Views 164

Elevating Leadership at Vortex Companies Vortex Companies, known for its rapid growth in the trenchless infrastructure rehabilitation sector, has recently made significant leadership changes with the promotions of Jonathan Thomas and Connor Mathis. Thomas steps into the role of Senior Regional Vice President for the Coastal Region, while Mathis ascends to Regional Vice...

Continue Reading
Scilex Holding Company Receives FDA Acknowledgment for ELYXYB

Updated Category News Views 118

Scilex Holding Company’s FDA Milestone with ELYXYB Scilex Holding Company, based in Palo Alto, California, has gained significant recognition with the U.S. FDA's acknowledgment of their Supplemental New Drug Application (SNDA) for ELYXYB. This marks a substantial step forward for the company, which is dedicated to creating and advancing non-opioid pain management...

Continue Reading
Bio-Techne Expands AI-Driven Protein Portfolio

Updated Category News Views 8

Advanced Proteins in the Spotlight Bio-Techne’s latest move is creating some serious buzz in the life sciences scene. They're not just talking the talk but walking the walk by expanding their R&D Systems AI-Engineered Designer Protein portfolio. What's the big news? They've engineered heat-stable and hyperactive proteins that promise to shake up fibroblast growth factor...

Continue Reading
PolyPid's D-PLEX100 Trial Results Revolutionize Infection Prevention

Updated Category News Views 146

Groundbreaking Advances in Surgical Infection Prevention PolyPid Ltd. has made headlines recently, unveiling remarkable topline results from their pivotal SHIELD II Phase 3 trial. This innovative study showcased D-PLEX100, a major breakthrough in preventing surgical site infections (SSIs), showing statistically significant reductions in both primary and secondary...

Continue Reading